Showing results (261-270 of 3,469) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|May 27, 2022
Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized StudyChristian Friedrich, Klaus Francke, Isabella Gashaw, et al.Clinical Pharmacokinetics|May 17, 2022
Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion ExperimentsV E Bukkems, H van Hove, D Roelofsen, et al.Clinical Pharmacokinetics|May 1, 1986
Reduction of paracetamol and aspirin metabolism during viral hepatitisC Jorup-Rönström, B Beermann, E Wåhlin-Boll, et al.Clinical Pharmacokinetics|October 29, 1997
Pharmacokinetic considerations of new insulin formulations and routes of administrationA Hoffman, E ZivClinical Pharmacokinetics|October 29, 1997
Clinical pharmacokinetic considerations in the elderly. An updateM T Kinirons, P CromeClinical Pharmacokinetics|September 1, 1985
Serum protein binding of tolbutamide in patients treated with antiepileptic drugsM C Fernández, S Erill, M I Lucena, et al.Clinical Pharmacokinetics|August 1, 1997
Pharmacokinetic interactions between alcohol and other drugsA G FraserClinical Pharmacokinetics|August 1, 1997
Clinical pharmacokinetics and pharmacodynamics of selegiline. An updateI MahmoodClinical Pharmacokinetics|August 1, 1997
Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methodsR Mehvar, F JamaliPageof 347